CapitalStars Updates:
INDIAN BENCHMARKS are
likely to start the session on a subued note as the global cues look muted with
SGX Nifty trading 108.50 points lower.
- Lupin receive USFDA approval for Fenofibrate tablets
- Maruti increases prices of vehicles by Rs3,000-9,000
- Ageas likely to hike stake in IDBI Federal Life
Trend in FII flows: The
FIIs were net sellers of Rs - 1007.26 Cr in the cash
segment on Thursday while the DIIs were net buyers of Rs 567.87 Cr,
as per the provisional figures released by the NSE.
CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on social network
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.
www.capitalstars.com | T:+91-731-6790000,6669900
CapitalStars Financial Research Financial Advisory Services
0 comments:
Post a Comment